CLINICAL ROLE -
Trending News Today: Legislators May Take Measured Approach to ACA Repeal
Top news of the day from across the healthcare landscape.
Read More
Amprya Bioequivalent Approved for Multiple Sclerosis
Dalfampridine extended-release tablets deemed bioequivalent of Amprya.
Bioequivalent Multiple Sclerosis Drug Approved by FDA
Dalfampridine extended-release tablets is the bioequivalent of Amprya.
Time and Education Are Key in Improving Flu Vaccine Uptake in Older Patients
All over the United States, outpatient clinics and emergency rooms are inundated with patients who report fever, chills, and cough all winter.
Researchers Focus on Survival Gene and Superbug Mutations
Antimicrobial-resistant infections have become an alarming threat to public health. Drug-resistant tuberculosis (TB) is a particularly widespread issue that can be especially damaging or fatal.
Specialty Pharmacy Dispute With Express Scripts Rages Over Network Removal
Prime Aid alleges that Express Scripts removed the pharmacy from their network to steer customers towards Accredo.
Prime Aid V. Express Scripts: A Case of Greed or Contractual Liability?
Specialty pharmacy squares off with pharmacy benefit manager over contractual dispute.
Ovarian Cancer Drug Could Expand-Use for Other Cancer Types
PGAM1 inhibitors sensitize tumors to lynparza (Olaparib) treatment.
Statins Can Destroy Cancer-Causing Mutated Proteins
Statins degrade mutated p53 proteins, offering future cancer treatment.
Pharmaceutical Alliance to Create Pediatric Epilepsy Drugs
TAK-935 will be developed to treat patients with rare pediatric epilepsy syndromes.
FDA Approves Latuda for Adolescent Schizophrenia
Latuda is the first drug approved in 5 years for the treatment of adolescent schizophrenia.
Genetic Alterations Predict Treatment Success in High-Risk Pediatric Leukemia
Poor long-term survival rates for pediatric patients with acute megakaryoblastic leukemia.
Ministrokes May Cause More Damage than Previously Thought
Ministrokes were observed to depress the affected area for up to 17 days.
Extended Fatty Liver Index More Accurately Predicts Non-Alcoholic Fatty Liver Disease
New index more precisely determines the probability of reducing liver fat during lifestyle interventions.
Gut Bacteria Plays a Role in Type 1 Diabetes
The microbiome and inflammatory signature differs in patients with type 1 diabetes.
Early Clinical Trial of Prostate Cancer Vaccine Commences
PAN-301-1 is a vaccine candidate to treat patients with persistent prostate cancer.
Oral Drug a Candidate to Treat Anemia from Chronic Kidney Disease
Oral ferric citrate may affectively raise hemoglobin levels in patients with anemia.
Trending News Today: Monsanto Suit Fights Against Cancer Warning Label on Weed Killer
Top news of the day from across the health care landscape.
Trending News Today: ACA Repeal May Lead to Higher Insurance Premiums for Older Adults
Uveitis Risk May be Elevated in Patients with Multiple Sclerosis
Conflicting evidence surrounds the association between multiple sclerosis and uveitis.
FDA Warns Belladonna Found in Homeopathic Teething Products
Elevated levels of belladonna could pose a risk to infants and children.
3 Things You Should Know About Scarlet Fever
Scarlet fever, also known as scarlatina, is a bacterial infection caused by group A Streptococcus or “group A strep.”
Patient Counseling: Most Important Opioid Warnings
Before you read this article, take a moment and see if you remember the 7 or 8 black box warnings associated with long acting opioid pain medications.
3 Things You Should Know About the Recent Mumps Outbreak
Mumps is a highly contagious disease caused by a virus that spreads through direct contact with respiratory secretions.
My Response When People Tell Me to Stop 'Promoting Drugs'
When people tell me to stop promoting drugs and start promoting lifestyle
Implications of Medicaid Expansion Highlights AJPB Week in Review
Top articles of the week from The American Journal of Pharmacy Benefits.
Findings from Gastrointestinal Symposium Top Week in Cancer News
Top news of the week in oncology and cancer drug development.
FDA Approves Ampyra Bioequivalent for Multiple Sclerosis
The FDA has given final approval to Aurobindo Pharma Limited for dalfampridine extended-release tablets (10 mg).
Treating Sleep-Related Symptoms in Muscular Dystrophy Proves Difficult
Characterizing a patient’s symptoms may improve sleep problems.
World Remains Unprepared for Future Infectious Disease Outbreaks
Most of the Ebola-related deaths in West Africa could have been prevented, experts say.
